New Recs for RBC Transfusion, Optimal RBC Storage Length

Share this content:
New Recs for RBC Transfusion, Optimal RBC Storage Length
New Recs for RBC Transfusion, Optimal RBC Storage Length

MONDAY, Oct. 17, 2016 (HealthDay News) -- In a clinical practice guideline published online Oct. 12 in the Journal of the American Medical Association, recommendations are presented for the target hemoglobin level for red blood cell (RBC) transfusion and optimal duration of RBC storage.

Jeffrey L. Carson, M.D., from Rutgers University in New Brunswick, N.J., and colleagues developed recommendations for the target hemoglobin level for RBC transfusion among hospitalized adult patients who are hemodynamically stable, as well as optimal storage time for RBCs prior to transfusion. Data were reviewed from randomized clinical trials (RCTs) evaluating hemoglobin thresholds for RBC transfusion (31 RCTs with 12,587 participants) and RBC storage duration (13 RCTs with 5,515 participants).

The researchers note that when making transfusion decisions regarding an individual patient, the hemoglobin level, overall clinical context, patient preferences, and alternative therapies should be considered. For hospitalized adults who are hemodynamically stable, including critically ill patients, a restrictive RBC transfusion threshold in which transfusion is not indicated until the hemoglobin level is 7 g/dL is recommended. For patients undergoing orthopedic and cardiac surgery and those with preexisting cardiac disease, a restrictive RBC transfusion threshold of 8 g/dL is recommended. Patients should receive RBC units selected at any point within their licensed dating period (storage length: <10 days).

"A restrictive transfusion threshold is safe in most clinical settings and the current blood banking practices of using standard-issue blood should be continued," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical technology industries.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »